766 related articles for article (PubMed ID: 14727968)
1. New targets for antithrombotic drugs.
Thiagarajan P
Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
[TBL] [Abstract][Full Text] [Related]
2. Recent insights on biochemical and molecular basis for developing antihaemostatic agents: A review.
Kumar R; Singh N; Singh K; Kalhan A; Prasad KK
Indian J Clin Biochem; 2004 Jan; 19(1):122-8. PubMed ID: 23105443
[TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
4. Management of thrombotic and cardiovascular disorders in the new millenium.
Fareed J; Hoppensteadt DA; Bick RL
Clin Appl Thromb Hemost; 2003 Apr; 9(2):101-8. PubMed ID: 12812377
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic drugs in vascular medicine: a historical perspective.
Schrör K
Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
[TBL] [Abstract][Full Text] [Related]
6. Novel antithrombotic drugs in development.
Verstraete M; Zoldhelyi P
Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602
[TBL] [Abstract][Full Text] [Related]
7. The role of the platelet in the pathogenesis of atherothrombosis.
Steinhubl SR; Moliterno DJ
Am J Cardiovasc Drugs; 2005; 5(6):399-408. PubMed ID: 16259528
[TBL] [Abstract][Full Text] [Related]
8. Formation and regulation of platelet and fibrin hemostatic plug.
Hawiger J
Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
[TBL] [Abstract][Full Text] [Related]
10. Advances in antithrombotic agents.
Chakrabarti R; Das SK
Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
[TBL] [Abstract][Full Text] [Related]
11. [Haemostaseology].
Schrör K
Internist (Berl); 2005 Aug; 46(8):873-8, 880-1. PubMed ID: 15988604
[TBL] [Abstract][Full Text] [Related]
12. Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents.
Goto S
Curr Vasc Pharmacol; 2004 Jan; 2(1):23-32. PubMed ID: 15320830
[TBL] [Abstract][Full Text] [Related]
13. Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy.
Sakariassen KS; Hanson SR; Cadroy Y
Thromb Res; 2001 Nov; 104(3):149-74. PubMed ID: 11672758
[TBL] [Abstract][Full Text] [Related]
14. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
15. Anti-thrombotic Effects Mediated by a Novel Dual-Target Peptide Inhibiting Both Platelet Aggregation and Thrombin Activity without Causing Bleeding.
Yu J; Wang T; Zhang X; Chen Q; Hu Y; Liang Q; Shi Y; Wang Y; Zhang Y; Yu M; Zhao B
Thromb Haemost; 2024 Feb; 124(2):108-121. PubMed ID: 37657484
[TBL] [Abstract][Full Text] [Related]
16. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
17. On the coagulation of platelet-rich plasma. Physiological mechanism and pharmacological consequences.
Béguin S; Keularts I
Haemostasis; 1999 Sep; 29(1):50-7. PubMed ID: 10494034
[TBL] [Abstract][Full Text] [Related]
18. An update on heparins at the beginning of the new millennium.
Fareed J; Hoppensteadt DA; Bick RL
Semin Thromb Hemost; 2000; 26 Suppl 1():5-21. PubMed ID: 11011802
[TBL] [Abstract][Full Text] [Related]
19. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition.
Ferguson JJ; Waly HM; Wilson JM
Eur Heart J; 1998 Apr; 19 Suppl D():D3-9. PubMed ID: 9597517
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
